NU SKIN ENTERPRISES, INC. (NUS) Form 8-K — Aug 10, 2026
Nu Skin Enterprises reported Q2 2026 revenue of $320.1 million, down 17.1% year over year, with GAAP EPS of $(5.14) versus $0.43 in the prior-year quarter. Adjusted EPS was $0.20 excluding a $78.9 million non-cash impairment charge and non-cash tax charges. The quarter produced a $249.8 million net loss, driven by the impairment (goodwill fell from $83.6 million to $4.8 million) plus a $167.5 million valuation allowance on deferred tax assets. Customer counts fell 14% to 660,037 and paid affiliates declined 8%, signaling continued erosion of the direct-selling base.
Key figures
- Revenue
- 320112000
- Guidance
- Q3 2026 revenue $310-$340 million ((15)% to (7)%); Q3 2026 EPS $0.00-$0.09 GAAP / $0.10-$0.20 adjusted; FY2026 revenue $1.28-$1.35 billion ((14)% to (9)%); FY2026 EPS ($4.90)-($4.73) GAAP / $0.70-$0.90 adjusted
- Revenue Yoy
- -17.1%
- Total Assets
- 1121530000
- Cash Position
- 189643000
- Customers
- 660037
- Fx impact
- (1.0)% or $(4.0) million
- Gross margin
- 68.2% vs 68.8% prior year
- Customers yoy
- -14%
- Sales leaders
- 26998
- Prior year eps
- 0.43
- Paid affiliates
- 120291
- Goodwill decline
- $83.6 million to $4.8 million
- Operating margin
- (18.5)% GAAP / 6.1% adjusted vs 8.0% prior year
- Sales leaders yoy
- -9%
- Paid affiliates yoy
- -8%
- Adjusted eps q2 2026
- 0.2
- Dividend payments q2
- 2900000
- Stock repurchases q2
- 0
- Impairment charges h1
- 80714000
- Impairment charges q2
- 78875000
- Remaining buyback authorization
- 137300000
- Deferred tax valuation allowance
- 167505000
Price after filing
Close on the filing date to close N calendar days later (from $5.49). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.